FOEHR MATTHEW W sold 10.8% of their position (16K shares) of VIKING THERAPEUTICS, INC. on the open market
Open‑market sale worth $561.7K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
Common Stock, par value $0.00001 per share
Shares
+16K
Price / share
$3.33
Trade value
$53.28K
% of position
Common Stock, par value $0.00001 per share
Shares
−16K
Price / share
$35.11
Trade value
$561.69K
% of position
Common Stock, par value $0.00001 per share
Shares
+3.15K
Price / share
—
Trade value
—
% of position
Net shares
+3.15K
Net value
-$508.41K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.00001 per share Direct | 1/2/2026 | M · Option Exercise | +16K | $3.33 | $53.28K | 12.1% | 132.04K | 148.04K |
| Common Stock, par value $0.00001 per share Direct | 1/2/2026 | S · Sale | −16K | $35.11 | $561.69K | 10.8% | 148.04K | 132.04K |
| Common Stock, par value $0.00001 per share Direct | 1/2/2026 | A · Award | +3.15K | — | — | 2.4% | 132.04K | 135.19K |
| Total | +3.15K | -$508.41K | ||||||
Stock Option (Right to Buy)
Common Stock
16K shares
Shares
−16K
Strike price
3.33
Held after
0.00
Exercisable
—
Stock Option (Right to Buy)
Common Stock
20.40K shares
Shares
+20.40K
Strike price
35.42
Held after
20.40K
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock16K shares | 1/2/2026 | M · Option Exercise | −16K | 3.33 | — | 0.00 |
| Stock Option (Right to Buy) Direct | Common Stock20.40K shares | 1/2/2026 | A · Award | +20.40K | 35.42 | — | 20.40K |